|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2022―Jul―01 |
COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria |
Alexandra Pike, Claire McKinley, Briony Forrest, Rebecca Scott, Emily Charlton, Emma Scott, Tapiwa Zhakata, Mark Harland, Deborah Clarke, John R Davies, Aurora Toogood, Nicola Houghton, Nora Youngs, Catherine Barnfield, Stephen Richards, Daniel Payne, Louise Arnold, Tahla Munir, Petra Muus, Morag Griffin, Richard J Kelly, Peter Hillmen, Darren Newton |
2 |
[GO] |
2022―Jun―30 |
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial |
Frank Cools, Saverio Virdone, Jitendra Sawhney, Renato D Lopes, Barry Jacobson, Juan I Arcelus, F D Richard Hobbs, Harry Gibbs, Jelle C L Himmelreich, Peter MacCallum, Sebastian Schellong, Sylvia Haas, Alexander G G Turpie, Walter Ageno, Ana Thereza Rocha, Gloria Kayani, Karen Pieper, Ajay K Kakkar, Ajit Avhad, Murillo Antunes, Ana Thereza Rocha, Jesus Gonzales Lama, Atul Abyankar, Adrian Paulo Morales Kormann, Louis Van Zyl, Upendra Kaul, Frances Adams, Ivan Aloysius, Matthew Capehorn, Pradeep Kumar, Rajesh Mahajan |
3 |
[GO] |
2022―Jun―30 |
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial |
Stefano Barco, Davide Voci, Ulrike Held, Tim Sebastian, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, André Frenk, Bernhard Gerber, Andrea Götschi, Stavros V Konstantinides, François Mach, Helia Robert-Ebadi, Thomas Rosemann, Noemi R Simon, Hervé Spechbach, David Spirk, Stefan Stortecky, Lukas Vaisnora, Marc Righini, Nils Kucher |
4 |
[GO] |
2022―Jun―30 |
Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more |
Jean M Connors, Paul M Ridker |
5 |
[GO] |
2022―Apr―25 |
Telemedicine for rural and regional patient access to haematology services during the COVID-19 pandemic in Australia |
Helen Cashman, Sathia Sushil, Eleni Mayson, Samuel Milliken, Orly Lavee, Alex Awford, Nada Hamad |
6 |
[GO] |
2022―Apr―01 |
Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT |
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, Florence Beckerich, Christine Robin, Vincent Parinet, Cécile Pautas, Dehbia Menouche, Selwa Bouledroua, Lydia Roy, Ludovic Cabanne, Yakout Nait-Sidenas, Elham Harfouch, Eric Gautier, Slim Fourati, Sébastien Maury |
7 |
[GO] |
2021―Dec―28 |
Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events |
Charles L Bennett, Krishna Gundabolu, Larry W Kwak, Benjamin Djulbegovic, Oscar Champigneulle, Brian Josephson, Linda Martin, Steven T Rosen |
8 |
[GO] |
2021―Oct―28 |
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network |
Heinz Ludwig, Pieter Sonneveld, Thierry Facon, Jesus San-Miguel, Hervé Avet-Loiseau, Mohamad Mohty, Maria-Victoria Mateos, Philippe Moreau, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Monika Engelhardt, Christoph Driessen, Gordon Cook, Melitios A Dimopoulos, Francesca Gay, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel, Graham Jackson, Laurent Garderet, Niels van de Donk, Xavier Leleu, Hartmut Goldschmidt, Meral Beksac, Inger Nijhof, Martin Schreder, Niels Abildgaard, Roman Hajek, Niklas Zojer, Efstathios Kastritis, Annemiek Broijl, Fredrik Schjesvold, Mario Boccadoro, Evangelos Terpos |
9 |
[GO] |
2021―Jul―02 |
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study |
Kazimieras Maneikis, Karolis Šablauskas, Ugnė Ringelevičiūtė, Vilmantė Vaitekėnaitė, Rita Čekauskienė, Lina Kryžauskaitė, Daniel Naumovas, Valdas Banys, Valdas Pečeliūnas, Tumas Beinortas, Laimonas Griškevičius |
10 |
[GO] |
2021―Jul―02 |
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma |
Sean H Lim, Nicola Campbell, Marina Johnson, Debora Joseph-Pietras, Graham P Collins, Ann O'Callaghan, Christopher P Fox, Matthew Ahearne, Peter W M Johnson, David Goldblatt, Andrew J Davies |
11 |
[GO] |
2021―Jun―22 |
Sustained prothrombotic changes in convalescent patients with COVID-19 |
Fien A von Meijenfeldt, Charlotte Thålin, Ton Lisman |
12 |
[GO] |
2021―Apr―27 |
COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year |
Jenneke Leentjens, Thijs F van Haaps, Pieter F Wessels, Roger E G Schutgens, Saskia Middeldorp |
13 |
[GO] |
2021―Apr―21 |
COVID-19 vaccines: building and maintaining confidence |
The Lancet Haematology |
14 |
[GO] |
2021―Apr―20 |
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma |
Sarah Bird, Aikaterini Panopoulou, Robyn L Shea, Micky Tsui, Radovan Saso, Amit Sud, Sharon West, Katy Smith, John Barwood, Ewa Kaczmarek, Carmela Panlaqui, Martin Kaiser, Simon Stern, Charlotte Pawlyn, Kevin Boyd |
15 |
[GO] |
2021―Apr―01 |
COVID-19 vaccines for patients with haematological conditions |
Clare Sun, Christopher Pleyer, Adrian Wiestner |
16 |
[GO] |
2021―Mar―23 |
A century between pandemics and poisonings |
Matthew D Seftel, Vernon Louw |
17 |
[GO] |
2021―Feb―03 |
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors |
Mathieu Leclerc, Slim Fourati, Dehbia Menouche, Dominique Challine, Sébastien Maury |
18 |
[GO] |
2021―Jan―26 |
COVID-19 and thrombosis: a continuing story |
The Lancet Haematology |
19 |
[GO] |
2021―Jan―26 |
COVID-19 vaccination in haematology services |
The Lancet Haematology |
20 |
[GO] |
2021―Jan―19 |
A rationale to prioritise vaccination of HSCT patients against COVID-19 |
Mathieu Leclerc, Sébastien Maury |
21 |
[GO] |
2021―Jan―19 |
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study |
Akshay Sharma, Neel S Bhatt, Andrew St Martin, Muhammad Bilal Abid, Jenni Bloomquist, Roy F Chemaly, Christopher Dandoy, Jordan Gauthier, Lohith Gowda, Miguel-Angel Perales, Stuart Seropian, Bronwen E Shaw, Eileen E Tuschl, Amer M Zeidan, Marcie L Riches, Gunjan L Shah |
22 |
[GO] |
2020―Sep―22 |
Routine haematological parameters in COVID-19 prognosis |
David Pereyra, Stefan Heber, Bernd Jilma, Alexander Zoufaly, Alice Assinger |
23 |
[GO] |
2020―Aug―24 |
Bringing hospital care closer to patients amidst COVID-19 |
Raul Cordoba |
24 |
[GO] |
2020―Aug―24 |
COVID-19 and haematology-oncology services |
The Lancet Haematology |
25 |
[GO] |
2020―Aug―13 |
COVID-19 and haematological malignancy: navigating a narrow strait |
Samuel M Rubinstein, Jeremy L Warner |
26 |
[GO] |
2020―Aug―13 |
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study |
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, Riccardo Bruna, Michele Cavo, Francesco Merli, Emanuele Angelucci, Mauro Krampera, Roberto Cairoli, Matteo Giovanni Della Porta, Nicola Fracchiolla, Marco Ladetto, Carlo Gambacorti Passerini, Marco Salvini, Monia Marchetti, Roberto Lemoli, Alfredo Molteni, Alessandro Busca, Antonio Cuneo, Alessandra Romano, Nicola Giuliani, Sara Galimberti, Alessandro Corso, Alessandro Morotti, Brunangelo Falini, Atto Billio, Filippo Gherlinzoni, Giuseppe Visani, Maria Chiara Tisi, Agostino Tafuri, Patrizia Tosi, Francesco Lanza, Massimo Massaia, Mauro Turrini, Felicetto Ferrara, Carmela Gurrieri, Daniele Vallisa, Maurizio Martelli, Enrico Derenzini, Attilio Guarini, Annarita Conconi, Annarosa Cuccaro, Laura Cudillo, Domenico Russo, Fabrizio Ciambelli, Anna Maria Scattolin, Mario Luppi, Carmine Selleri, Elettra Ortu La Barbera, Celestino Ferrandina, Nicola Di Renzo, Attilio Olivieri, Monica Bocchia, Massimo Gentile, Francesco Marchesi, Pellegrino Musto, Augusto Bramante Federici, Anna Candoni, Adriano Venditti, Carmen Fava, Antonio Pinto, Piero Galieni, Luigi Rigacci, Daniele Armiento, Fabrizio Pane, Margherita Oberti, Patrizia Zappasodi, Carlo Visco, Matteo Franchi, Paolo Antonio Grossi, Lorenza Berté, Giovanni Corrao, Livio Pagano, Paolo Corradini |
27 |
[GO] |
2020―Jul―10 |
Coagulation disorder in COVID-19 |
Thomas Kander |
28 |
[GO] |
2020―Jul―10 |
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study |
Danying Liao, Fen Zhou, Lili Luo, Min Xu, Hongbo Wang, Jiahong Xia, Yong Gao, Liqiong Cai, Zhihui Wang, Ping Yin, Yadan Wang, Lu Tang, Jun Deng, Heng Mei, Yu Hu |
29 |
[GO] |
2020―Jul―03 |
Effects of the COVID-19 pandemic on supply and use of blood for transfusion |
Simon J Stanworth, Helen V New, Torunn O Apelseth, Susan Brunskill, Rebecca Cardigan, Carolyn Doree, Marc Germain, Mindy Goldman, Edwin Massey, Daniele Prati, Nadine Shehata, Cynthia So-Osman, Jecko Thachil |
30 |
[GO] |
2020―Jun―30 |
Endothelial cells orchestrate COVID-19 coagulopathy |
Jamie M O'Sullivan, Dennis Mc Gonagle, Soracha E Ward, Roger J S Preston, James S O'Donnell |
31 |
[GO] |
2020―Jun―30 |
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study |
George Goshua, Alexander B Pine, Matthew L Meizlish, C-Hong Chang, Hanming Zhang, Parveen Bahel, Audrey Baluha, Noffar Bar, Robert D Bona, Adrienne J Burns, Charles S Dela Cruz, Anne Dumont, Stephanie Halene, John Hwa, Jonathan Koff, Hope Menninger, Natalia Neparidze, Christina Price, Jonathan M Siner, Christopher Tormey, Henry M Rinder, Hyung J Chun, Alfred I Lee |
32 |
[GO] |
2020―Jun―18 |
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts |
Amer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K Rampal, Rory Shallis, David P Steensma, Michael R Savona, Mikkael A Sekeres, Gail J Roboz, Daniel J DeAngelo, Andre C Schuh, Eric Padron, Joshua F Zeidner, Roland B Walter, Francesco Onida, Amir Fathi, Amy DeZern, Gabriela Hobbs, Eytan M Stein, Paresh Vyas, Andrew H Wei, David T Bowen, Pau Montesinos, Elizabeth A Griffiths, Amit K Verma, Alla Keyzner, Michal Bar-Natan, Shyamala C Navada, Marina Kremyanskaya, Aaron D Goldberg, Aref Al-Kali, Mark L Heaney, Aziz Nazha, Huda Salman, Selina Luger, Keith W Pratz, Heiko Konig, Rami Komrokji, Michael Deininger, Blanca Xicoy Cirici, Vijaya Raj Bhatt, Lewis R Silverman, Harry P Erba, Pierre Fenaux, Uwe Platzbecker, Valeria Santini, Eunice S Wang, Martin S Tallman, Richard M Stone, John Mascarenhas |
33 |
[GO] |
2020―Jun―18 |
Prognosis of patients with sickle cell disease and COVID-19: a French experience |
Jean-Benoît Arlet, Gonzalo de Luna, Djamal Khimoud, Marie-Hélène Odièvre, Mariane de Montalembert, Laure Joseph, Christelle Chantalat-Auger, Edouard Flamarion, Pablo Bartolucci, François Lionnet, Sebastien Monnier, Cécile Guillaumat, Aline Santin |
34 |
[GO] |
2020―May―26 |
COVID-19 coagulopathy: an evolving story |
The Lancet Haematology |
35 |
[GO] |
2020―May―25 |
Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19 |
Wanxin Chen, Bohan Yang, Ziping Li, Ping Wang, Yan Chen, Hao Zhou |
36 |
[GO] |
2020―May―22 |
Following-up allogeneic transplantation recipients during the COVID-19 pandemic |
Maria Teresa Lupo-Stanghellini, Carlo Messina, Sarah Marktel, Matteo G. Carrabba, Jacopo Peccatori, Consuelo Corti, Fabio Ciceri |
37 |
[GO] |
2020―May―11 |
Coagulation abnormalities and thrombosis in patients with COVID-19 |
Marcel Levi, Jecko Thachil, Toshiaki Iba, Jerrold H Levy |
38 |
[GO] |
2020―Apr―27 |
Management of patients with multiple myeloma during the COVID-19 pandemic |
Florent Malard, Mohamad Mohty |
39 |
[GO] |
2020―Apr―24 |
Effect of the COVID-19 pandemic on cancer treatment and research |
Kamal S Saini, Begoña de las Heras, Javier de Castro, Ramachandran Venkitaraman, Martine Poelman, Gopalakrishnan Srinivasan, Monika Lamba Saini, Sanjeev Verma, Manuela Leone, Philippe Aftimos, Giuseppe Curigliano |
40 |
[GO] |
2020―Apr―23 |
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries |
Daniel Dexter, David Simons, Charles Kiyaga, Nathan Kapata, Francine Ntoumi, Richard Kock, Alimuddin Zumla |
41 |
[GO] |
2020―Apr―09 |
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19 |
Tao Wang, Ruchong Chen, Chunli Liu, Wenhua Liang, Weijie Guan, Ruidi Tang, Chunli Tang, Nuofu Zhang, Nanshan Zhong, Shiyue Li |
42 |
[GO] |
2020―Apr―01 |
Strategic plan for management of COVID-19 in paediatric haematology and oncology departments |
Yulei He, Zhi Lin, Daolin Tang, Yang Yang, Tianyou Wang, Minghua Yang |
43 |
[GO] |
2020―Apr―01 |
Handling the COVID-19 pandemic in the oncological setting |
Alberto Mussetti, Clara Maluquer, Adaia Albasanz-Puig, Carlota Gudiol, Gabriel Moreno-Gonzalez, Paolo Corradini, Anna Sureda |
44 |
[GO] |
2020―Mar―24 |
COVID-19 in a patient with chronic lymphocytic leukaemia |
Xiang-Hong Jin, Kenneth I Zheng, Ke-Hua Pan, Yu-Peng Xie, Ming-Hua Zheng |
|